Tirzepatide also contributed to substantial weight loss in participants with pre-diabetes and obesity or overweight: At week 176, those taking tirzepatide achieved average weight reductions of 15.4% (5 mg), 19.9% (10 mg), and 22.9% (15 mg), respectively, compared to 2.1% for placebo
There are some companies out there that are no longer using BMI restrictions to disqualify patients, like Josie and Willow
Lunch is a small teriyaki chicken bowl with rice and broccoli, 32g protein, small enough to actually finish
These providers may prescribe medications for metabolic health when clinically appropriate
And ive got chronic fatigue syndrome as one factor of long Covid
For instance, a trial of an IL-6 inhibitor could target patients identified as having a high IL-6 genotype or high pre-op IL-6 levels, to enrich for those likely to benefit